These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18635926)

  • 21. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
    Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
    Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive role of BNP and NT-proBNP in hemodialysis patients.
    Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C
    Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective.
    Abassi Z; Nakhoul F; Khankin E; Reisner SA; Yigla M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):353-60. PubMed ID: 16775448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Background diseases in 671 patients with moderate to severe pulmonary hypertension.
    Yigla M; Dabbah S; Azzam ZS; Rubin AH; Reisner SA
    Isr Med Assoc J; 2000 Sep; 2(9):684-9. PubMed ID: 11062769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients.
    Unal A; Tasdemir K; Oymak S; Duran M; Kocyigit I; Oguz F; Tokgoz B; Sipahioglu MH; Utas C; Oymak O
    Hemodial Int; 2010 Oct; 14(4):398-402. PubMed ID: 20854331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.
    Drewniak W; Snopek G; Zarukiewicz M; Borys M; Dabrowski M
    Kardiol Pol; 2008 Jul; 66(7):750-5; discussion 756-7. PubMed ID: 18690566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation.
    Bozbas SS; Akcay S; Altin C; Bozbas H; Karacaglar E; Kanyilmaz S; Sayin B; Muderrisoglu H; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2753-6. PubMed ID: 19765426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of NT-proBNP in assessment of right ventricular function in children after tetralogy of Fallot correction - a preliminary study.
    Pietrzak R; Werner B
    Kardiol Pol; 2009 Apr; 67(4):378-83. PubMed ID: 19492250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular reverse remodeling early after mitral valve repair for severe chronic mitral regurgitation with atrial fibrillation.
    Song BG; On YK; Jeon ES; Park JH; Choi JO; Lee SC; Park SW; Kim JS; Park PW
    Cardiology; 2009; 114(2):132-41. PubMed ID: 19521078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermography and colour duplex ultrasound assessments of arterio-venous fistula function in renal patients.
    Allen J; Oates CP; Chishti AD; Ahmed IA; Talbot D; Murray A
    Physiol Meas; 2006 Jan; 27(1):51-60. PubMed ID: 16365510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hypertension in patients with end stage renal disease undergoing hemodialysis.
    Tudoran M; Ciocarlie T; Mates A; Pescariu SA; AbuAwwad A; Tudoran C
    Niger J Clin Pract; 2020 Feb; 23(2):198-204. PubMed ID: 32031094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does arterio-venous fistula creation affects development of pulmonary hypertension in hemodialysis patients?
    Unal A; Duran M; Tasdemir K; Oymak S; Sipahioglu MH; Tokgoz B; Utas C; Oymak O
    Ren Fail; 2013; 35(3):344-51. PubMed ID: 23356711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of frequency of complications of arterio venous fistula in patients on dialysis: a two-year single center study from Iran.
    Derakhshanfar A; Gholyaf M; Niayesh A; Bahiraii S
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):872-5. PubMed ID: 19736495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients.
    Ortega O; Rodriguez I; Gracia C; Sanchez M; Lentisco C; Mon C; Gallar P; Ortiz M; Herrero JC; Oliet A; Vigil A
    Nephron Clin Pract; 2009; 113(2):c96-103. PubMed ID: 19602905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.